S1 Experimental
All reagents were purchased from Aldrich, Avocado, Fluka, Proligo, Applied Biosystems or Link Technologies and used without purification with the exception of DCM and di-isopropylethylamine (distilled over calcium hydride). Chemical transformations were carried out under an atmosphere of argon using oven-dried glassware. NAP gel-filtration columns were purchased from GE Healthcare and used according to the manufacturer's instructions. Column chromatography was carried out under pressure using Fisher Scientific DAVISIL 60A (35-70 microns) silica. Thin layer chromatography was performed using Merck Kieselgel 60 F 24 (0.22mm thickness, aluminium backed). Compounds were visualized using ultraviolet light and staining with potassium permanganate solution.
1 H NMR spectrum was measured at 400 MHz, and 13 C NMR spectra were measured at 100 MHz on a Brüker DPX 400
spectrometer. Chemical shifts are given in ppm relative to tetramethylsilane, and J values are given in Hz, and are correct to within 0.5 Hz. All spectra are internally referenced to the appropriate residual undeuterated solvent signal. Multiplicities of 13 C signals were determined using DEPT spectral editing technique. Low-resolution mass spectra were recorded in acetonitrile (HPLC grade) using electrospray technique on a Fisons VG platform instrument. High-resolution mass spectrum was recorded in acetonitrile using electrospray technique on a Brüker APEX III FT-ICR mass spectrometer. MALDI-TOF MS were recorded using a ThermoBioAnalysis Dynamo MALDI-TOF mass spectrometer in positive ion mode using oligonucleotide dT standards. After HPLC purification, oligonucleotides were desalted using NAP-10 Sephadex columns (GE Healthcare), aliquot into Eppendorf tubes and stored at -20 °C.
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Maleimide Labelling of Oligonucleotides
Coupling of maleimide to the 5'-or 3'-end of amino oligonucleotides was carried out by incubating the oligonucleotide (0.2 µmol) in 10 mM Na 2 HPO 4 /NaH 2 PO 4 buffer (pH 7.5, 70 µL) and the 6-maleimidohexanoic acid N-hydroxysuccinimide ester (4 µmol) in DMSO (30 µL) for 1 h at room temperature. The crude oligonucleotide was desalted by gel filtration using NAP-10 columns according to the manufacture's instructions (GE Healthcare), and characterized by MALDI-TOF mass spectrometry.
To avoid deactivation of the maleimide by reaction with water, the labelled oligonucleotides were freeze-dried immediately after gel filtration and stored at -20 ο C.
Synthesis of Furan-Labelled Oligonucleotides
Coupling of furan NHS ester at either the 5'-or the 3'-end of amino oligonucleotide was carried out by mixing the oligonucleotide (0.2 µmol) in 0.5 M Na 2 CO 3 /NaHCO 3 buffer (pH 8.75, 80 µL) and 3-(2-furyl) propanoic acid NHS ester (5 µmol) in DMSO (80 µL) for 4 h at room temperature. The crude oligonucleotides were desalted using NAP-10 columns according to the manufacturer's instructions (GE Healthcare), purified by reversed-phase HPLC, desalted again (NAP-10) and characterized by MALDI-TOF mass spectrometry.
Synthesis of Dual-Furan-Labelled Oligonucleotide
The 5', 3'-amino oligonucleotide was dual labelled with 3-(2-furyl) propanoic acid NHS ester by incubating the oligonucleotide (0.2 µmol) in 0.5 M Na 2 CO 3 /NaHCO 3 buffer (pH 8.75, 80 µL) in the presence of the furan active ester (12 µmol) in DMSO (80 µL) for 4 h at room temperature. The crude oligonucleotide was desalted by gel filtration using NAP-10 columns, purified by reversed-phase HPLC, desalted again on a NAP-10 column and characterized by MALDI-TOF mass spectrometry.
Template-Mediated Diels-Alder Reaction to form Type I Diels-Alder Ligated
Oligonucleotides 5'-Maleimide-labelled MO1 (9 nmol) was added to a solution of 3'-furan-labelled FO2
(9 nmol) and their complementary template TO3 (9 nmol) in 10 mM Type I Diels-Alder ligated LO4 was also prepared using 10 mM Na 2 HPO 4 /NaH 2 PO 4 , 0.2 M NaCl buffer (pH 7.0).
Template-Mediated Diels-Alder Reaction to form Type II Diels-Alder Ligated
Oligonucleotides 3'-Maleimide-labelled MO5 (9 nmol) was added to a solution of 5'-furan-labelled FO6
(9 nmol) and their complementary template TO7 (9 nmol) in 10 mM Type II Diels-Alder ligated LO8 was also prepared using 10 mM Na 2 HPO 4 /NaH 2 PO 4 , 0.2 M NaCl buffer (pH 7.0).
Template-Mediated Diels-Alder Ligation to form Type III Diels-Alder Ligated Oligonucleotides
A mixture of the 5'-and 3'-dual-furan-labelled FFO10 (6 nmol) with its complementary template TO11 (6 nmol) was annealed by heating at 80 °C for 5 min then allowed to cool to ambient temperature slowly (2 hr) in 10 mM Na 2 HPO 4 /NaH 2 PO 4 , 0.2 M NaCl buffer (pH 6.2, 300 µL). The solution was then added to the lyophilized 5'-maleimide-labelled MO1 (6 nmol) and 3'-maleimidelabelled MO5 (6 nmol). The reaction mixture was kept at room temperature and aliquots were taken at the desired time, desalted on a NAP-10 column (GE Healthcare), immediately freeze dried then analyzed by 20 % denaturing polyacrylamide gel electrophoresis.
For the non-annealing reaction conditions, the above procedure was repeated without heating, i.e. the mixture of the 5'-and 3'-dual-furan-labelled FFO10 and its complementary template TO11 were set aside at room temperature in buffer for 2 hr instead of heating/cooling.
After running the gel, the desired bands were excised, crushed, and incubated in 2 mL of sterile water at 37 °C for 18 hr. The tubes were then vortexed, centrifuged then the supernatant was desalted using NAP-25 column (GE Healthcare).
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S2: Ultraviolet melting studies
UV melting studies were performed using 1 µM oligonucleotide concentration in 10 mM Na 2 HPO 4 /NaH 2 PO 4 , 0.2 M NaCl buffer (pH 7) on a Varian Cary 400 scan UVvisible spectrophotometer. Hellma SUPRASIL synthetic quartz 10 mm path length cuvettes were used and T m values were calculated using Cary Win UV thermal application software. 
S4: Buffer Stability Studies on Maleimide-Labelled Oligonucleotides
5'-Maleimide-labelled MO1 and 3'-maleimide-labelled MO5 were separately dissolved in 10 mM Na 2 HPO 4 /NaH 2 PO 4 , 0.2 M NaCl buffer (pH 6.2 or pH 7 ). The reaction mixture were left at room temperature for 1 h, and then desalted on a NAP-10 column (GE Healthcare), and characterized by MALDI-TOF mass spectrometry.
MO1 and MO5 were also dissolved in 1X Tris-borate-EDTA buffer and incubated at 35 °C for 2 h (conditions for the polyacrylamide gel) before they were desalted on a NAP-10 column (GE Healthcare), analyzed by capillary electrophoresis, and characterized by ESI or MALDI-TOF mass spectrometry. The mass spectra showed only the correct mass for the 5'-and 3'-maleimide in phosphate buffer (pH 6.2 and 7).
In the case of the 1X TBE buffer it showed the correct mass in addition to M + +18
(hydrolysis) as shown below.
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Figure S1: Capillary electrophoresis (CE), of 5'-maleimide-labelled oligonucleotide MO1 before (A) and after (B) incubation in 1X TBE buffer at 35 °C, 2 h respectively. X-axis is time (min), Y-axis is UV absorbance at 254 nm. Oligonucleotides (0.4 OD/100 μL) were injected into a ssDNA 100-R Gel using Tris-Borate 
